STX
38
4
XRX
59
11
AVGO
76
2
XRAY
31
2
IVZ
48
6
AMG
49
14
NOV
47
2
QCOM
56
6
WBA
38
-3
EQT
50
3
RL
75
2
DVN
24
2
HIG
50
2
CHD
32
-2
INTC
37
2
NEM
41
9
VZ
22
-2
NWSA
71
2
PM
47
-2
PYPL
47
-2
STX
38
4
XRX
59
11
AVGO
76
2
XRAY
31
2
IVZ
48
6
AMG
49
14
NOV
47
2
QCOM
56
6
WBA
38
-3
EQT
50
3
RL
75
2
DVN
24
2
HIG
50
2
CHD
32
-2
INTC
37
2
NEM
41
9
VZ
22
-2
NWSA
71
2
PM
47
-2
PYPL
47
-2
Financhill
Back

Oxford Square Capital Vs. Novo Nordisk AS Industry Stock Comparison

Sell
27

OXSQ
Oxford Square Capital

Last Price:
$2.48
Seasonality Move:
-0.66%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$88.71
Seasonality Move:
6.58%
Sell
27
Oxford Square Capital (OXSQ) is a Sell

Is Oxford Square Capital a Buy, Sell or Hold?

  • The current Oxford Square Capital [OXSQ] share price is $2.48. The Score for OXSQ is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • OXSQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OXSQ Stock Price Chart

What is Oxford Square Capital's stock price today?

  • The Oxford Square Capital share price today is $2.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OXSQ is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $88.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

OXSQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 26.67 Sell
Chaikin Money Flow: -147931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.56 - 2.7) Sell
Bollinger Bands (100): (2.7 - 2.98) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 27.28 Sell
Chaikin Money Flow: 14079249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.16 - 111.42) Sell
Bollinger Bands (100): (106.53 - 131.27) Sell

OXSQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.56 Sell
20-day SMA: 2.62 Sell
50-day SMA: 2.76 Sell
200-day SMA: 2.96 Sell
8-day EMA: 2.54 Sell
20-day EMA: 2.61 Sell
50-day EMA: 2.71 Sell
200-day EMA: 2.9 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.84 Sell
20-day SMA: 105.84 Sell
50-day SMA: 108.65 Sell
200-day SMA: 126.03 Sell
8-day EMA: 99.1 Sell
20-day EMA: 103.93 Sell
50-day EMA: 109.19 Sell
200-day EMA: 117.8 Sell

Oxford Square Capital Earnings Growth & OXSQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.17 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Oxford Square Capital Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):